Lynnea Olivarez Email Address

Vice President, Corporate Communications

Intellia Therapeutics is a leading gene-editing company focused on the development of curative medicines using CRISPR/Cas9 technology

Lynnea Olivarez is a director at Ten Bridge Communications and has deep-seated experience as a biopharma communicator across a variety of organizations in the space. She most recently guided public relations strategy for more than a dozen life science companies as a member of MacDougall Biomedical Communications’ media practice. Lynnea spearheaded a range of strategic communications initiatives for her clients, including corporate messaging, media programs, social media engagement and crisis communications. Previously, Lynnea led marketing and communications activities for the Massachusetts Life Sciences Center, the agency charged with implementing the state’s $1-billion life science initiative. She helped elevate Massachusetts’ reputation as a leading life science hub, overseeing the center’s rebranding and launching targeted awareness campaigns for new funding programs, both internationally and domestically. Before her time in government, Lynnea managed global internal communications for Novartis Institutes for Biomedical Research’s informatics and technology team. She began her career in biopharma at the state’s industry trade association, MassBio. She graduated magna cum laude from Northeastern University with a bachelor's degree in journalism.